JERUSALEM, May 09, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for [...] Read more »
منصة BTCC تحقق نموًا ملحوظًا في الربع الأول من عام 2025: حجم تداول قياسي بلغ 815 مليار دولار، وحماية معززة للمستخدم، والمزيد من المبادرات التي تركز على المستخدم
فيلنيوس، ليتوانيا, April 28, 2025 (GLOBE NEWSWIRE) —
Read more »
BTCC Exchange Achieves Remarkable Growth in Q1 2025: Record Trading Volume of $815 Billion, Strengthened User Protection, and More User-Centric Initiatives
VILNIUS, Lithuania, April 25, 2025 (GLOBE NEWSWIRE) — Read more »
Unipart announces record performance for year ending 31 December 2024
Highlights
- Turnover increased to £1,081.1m, up 3.2% year–on–year
- Underlying PBIT grew 29.5% to £28.1m
- Balance sheet strengthened – net cash position at [...] Read more »
Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates
JERUSALEM, March 28, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key business [...] Read more »
Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates
JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptides and small therapeutic proteins, today [...] Read more »
Ittihad announces Half Year 2024 Financial Results
ABU DHABI, United Arab Emirates, Sept. 04, 2024 (GLOBE NEWSWIRE) — Ittihad International Investment LLC ("Ittihad"; the "Company"), the leading industrial conglomerate in the UAE, today announces its Half Year 2024 [...] Read more »
Yili Reports FY2024 H1 Revenue of 59.9 Billion Yuan with 19% YoY Growth in Net Profit Attributable to the Parent Company
HOHHOT, China, Sept. 02, 2024 (GLOBE NEWSWIRE) — On August 29, Yili Group (600887.SS) released its FY2024 H1 report. During the reporting period, the company continued to solidify its industrial leadership with a total revenue of [...] Read more »
Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates
JERUSALEM , Aug. 09, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, [...] Read more »